ABVX

#791
Abivax SA - American Depositary Shares
132.6 0 USD
+2.39%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
131.00
133.50
Range Annuel
5.69
148.83
Changement quotidien
+2.39%
Changement Mensuel
+22.22%
Evolution sur 6 mois
+5.87%
Changement Annuel
+2106.32%
Clôture Précédente
129.5 0
Open
131.7 8
Low
131.0 0
High
133.5 0
Volume
920
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202320242025 TTM

Abivax SA - American Depositary Shares

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France.

Nouvelles